The global virus filtration market size is expected to reach USD 13.86 billion by 2032, expected to grow at a CAGR of 14.1% during the forecast period.
The Virus Filtration Market refers to the industry involved in providing solutions for the removal or inactivation of viruses from liquids and gases used in various sectors, particularly in healthcare and biotechnology. Virus filtration is an essential process for ensuring the safety and purity of products, especially in the pharmaceutical, biopharmaceutical, and food industries, where the presence of viruses can cause severe health risks.
Growth Drivers of the Virus Filtration Market
- Increasing Demand for Biologics and Vaccines
- The growing demand for biologics, vaccines, and gene therapies has led to an increase in virus filtration applications. These products require stringent safety measures to ensure they are free from contaminants like viruses.
- Rising Public Health Concerns
- The COVID-19 pandemic has heightened awareness of viral transmission and contamination risks in medical products. This has led to increased investment in virus filtration technologies to ensure the safety and effectiveness of drugs, vaccines, and biologics.
- Stringent Regulatory Requirements
- Regulatory bodies such as the FDA, EMA, and WHO have set strict guidelines and standards for virus filtration in the pharmaceutical and biotechnology sectors. These regulations promote the adoption of filtration solutions to ensure compliance with safety standards.
Some of the major players operating in the global market include:
- Asahi Kasei Medical
- Charles River Laboratories International Inc
- Danaher
- Clean Cell Inc.
- GE Healthcare
- Lonza Group Ltd
- Merck KGaA
- Sartorius
- Qiagen
- Thermo Fisher Scientific Inc.
- WuXi PharmaTech
Download Free Sample PDF Copy of the Report:
https://www.polarismarketresearch.com/industry-analysis/virus-filtration-market/request-for-sample
Key Trends in the Virus Filtration Market
- Advancements in Nanofiltration and Microfiltration
- Nanofiltration and microfiltration techniques are gaining traction in the virus filtration market, offering higher selectivity and improved removal of viral particles compared to traditional filtration methods.
- Use of Single-Use Systems
- The use of single-use filtration systems is becoming more common due to their convenience, reduced contamination risks, and cost-effectiveness. This trend is particularly prevalent in biopharmaceutical and vaccine production.
- Integration of Automation and Digital Technologies
- Automation and digital technologies are increasingly integrated into virus filtration systems. These technologies enable real-time monitoring, data analytics, and enhanced control over filtration processes, improving operational efficiency.
Recent Developments
- In October 2022, PathoQuest has opened a new factory in Wayne, Pennsylvania. The facility spans 7000 square feet (650 square meters) and has already begun accepting new customers from around North America and the world. This will allow for the testing of groundbreaking biologics in the industry.
- In July 2022, Agilitech has launched a versatile single-use platform for virus filtration in bioprocessing. This system is designed for single-use and is highly efficient in filtering viruses.
𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬:
The research study includes segmental analysis that divides the market into distinct groups or segments based on common characteristics. With market segmentation, businesses can identify specific customer groups that are more likely to be interested in specific products or services. Also, it enables these businesses to focus their marketing efforts and resources more efficiently, leading to higher conversion rates and improved return on investment. Furthermore, segmentation analysis helps companies develop personalized products or services, which can result in increased customer loyalty and improved customer satisfaction.
Virus Filtration, Product Type Outlook (Revenue – USD Billion, 2019 – 2032)
- Consumables
- Instruments
- Services
- Others
Virus Filtration, Application Outlook (Revenue – USD Billion, 2019 – 2032)
- Biologicals
- Medical Devices
- Air Purification
- Water Purification
- Others
Virus Filtration, End-Use Outlook (Revenue – USD Billion, 2019 – 2032)
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Academic Research Institutes
- Medical Device Companies
- Contract Research Organizations
- Others
The virus filtration market is experiencing rapid growth, driven by the increasing demand for biologics, vaccines, and other therapeutics, as well as growing concerns about viral contamination in medical products. The market is expected to continue its upward trajectory, with advancements in filtration technologies, the expansion of the biopharmaceutical industry, and rising public health awareness driving demand for virus-free products.